TEST:

AVENIO Tumor Tissue CGP Kit

ABL1 (ABL proto-oncogene 1), AKT1 (V-akt murine thymoma viral oncogene homolog 1), ARID1A (AT-rich interaction domain 1A), AXIN1 (Axin 1), BAP1 (BRCA1 Associated Protein 1), BARD1 (BRCA1 Associated RING Domain 1), BCOR (BCL6 Corepressor), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), CCND3 (Cyclin D3), CCNE1 (Cyclin E1), CD22 (CD22 Molecule), CDK12 (Cyclin dependent kinase 12), CDK4 (Cyclin-dependent kinase 4), CDK6 (Cyclin-dependent kinase 6), CEBPA (CCAAT Enhancer Binding Protein Alpha), CHEK1 (Checkpoint kinase 1), CHEK2 (Checkpoint kinase 2), CREBBP (CREB binding protein), CTNNB1 (Catenin (cadherin-associated protein), beta 1), DNMT3A (DNA methyltransferase 1), EGFR (Epidermal growth factor receptor), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), ERBB4 (erb-b2 receptor tyrosine kinase 4), FANCC (FA Complementation Group C), FANCL (FA Complementation Group L), FGFR1 (Fibroblast growth factor receptor 1), FGFR2 (Fibroblast growth factor receptor 2), FGFR3 (Fibroblast growth factor receptor 3), FGFR4 (Fibroblast growth factor receptor 4), FLT1 (Fms-related tyrosine kinase 1), FLT3 (Fms-related tyrosine kinase 3), FOXL2 (Forkhead Box L2), GNA11 (G Protein Subunit Alpha 11), HER-2 (Human epidermal growth factor receptor 2), HRAS (Harvey rat sarcoma viral oncogene homolog), IDH1 (Isocitrate dehydrogenase (NADP(+)) 1), IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2), KDM5A (Lysine Demethylase 5A), KIT (KIT proto-oncogene, receptor tyrosine kinase), KMT2A (Lysine Methyltransferase 2A), KRAS (KRAS proto-oncogene GTPase), MET (MET proto-oncogene, receptor tyrosine kinase), MSH6 (MutS homolog 6), MUTYH (MutY homolog), NF1 (Neurofibromin 1), NF2 (Neurofibromin 2), NOTCH1 (Notch 1), NOTCH2 (Notch 2), NOTCH3 (Notch Receptor 3), NPM1 (Nucleophosmin 1), NRAS (Neuroblastoma RAS viral oncogene homolog), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3), PARP1 (Poly(ADP-Ribose) Polymerase 1), PARP3 (Poly(ADP-Ribose) Polymerase Family Member 3), PD-L1 (Programmed death ligand 1), PDK1 (Pyruvate Dehydrogenase Kinase 1), PIK3C2B (Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Beta), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), POLE (DNA Polymerase Epsilon), PTEN (Phosphatase and tensin homolog), PTPN11 (Protein Tyrosine Phosphatase Non-Receptor Type 11), RAD52 (RAD52 Homolog DNA Repair Protein), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), SMAD2 (SMAD Family Member 2), SMAD4 (SMAD family member 4), TET2 (Tet Methylcytosine Dioxygenase 2), TP53 (Tumor protein P53), VEGFA (Vascular endothelial growth factor A), mTOR (Mechanistic target of rapamycin kinase)